Search Results - "Pol, S"

Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling by Brimer, N, Lyons, C, Wallberg, A E, Vande Pol, S B

“…Papillomavirus E6 oncoproteins associate with LXXLL motifs on target cellular proteins to alter their function. Using a proteomic approach, we found the E6…”
Get full text

First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice by Pol, S., Lampertico, P.

“…Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos(t)ide analogues (NUCs) recommended as first‐line monotherapies for chronic hepatitis…”
Get full text

Avian mercury exposure and toxicological risk across western North America: A synthesis by Ackerman, Joshua T., Eagles-Smith, Collin A., Herzog, Mark P., Hartman, C. Alex, Peterson, Sarah H., Evers, David C., Jackson, Allyson K., Elliott, John E., Vander Pol, Stacy S., Bryan, Colleen E.

“…Methylmercury contamination of the environment is an important issue globally, and birds are useful bioindicators for mercury monitoring programs. The…”
Get full text

Executive Functioning in 60+ Autistic Males: The Discrepancy Between Experienced Challenges and Cognitive Performance by Geurts, Hilde M., Pol, S. E., Lobbestael, J., Simons, Claudia J. P.

“…As executive functioning (EF) is especially sensitive to age-related cognitive decline, EF was evaluated by using a multi-method assessment. Fifty males…”
Get full text

Long-Range and Local Structure in the Layered Oxide Li1.2Co0.4Mn0.4O2 by Bareño, J, Balasubramanian, M, Kang, S. H, Wen, J. G, Lei, C. H, Pol, S. V, Petrov, I, Abraham, D. P

“…The layered oxides being considered as intercalation compounds for lithium batteries display significant differences between the long-range crystal structure…”
Get full text

Methylmercury photodegradation influenced by sea-ice cover in Arctic marine ecosystems by Point, D, Moors, A. J, Hobson, K. A, Vander Pol, S. S, Pugh, R. S, Roseneau, D. G, Becker, P. R, Sonke, J. E, Donard, O. F. X, Day, R. D

“…Atmospheric deposition of mercury to remote areas has increased threefold since pre-industrial times. Mercury deposition is particularly pronounced in the…”
Get full text

Recent Trends and Scope of Nanotechnology in Orthopaedic Surgery: A Narrative Review by Pol, Shri Hari S

“…Orthopaedic implants osseointegrate better using nanophase materials because they mimic the natural trabecular bone structure better. Additionally, prostheses…”
Get full text

Age-associated systemic factors change central and peripheral immunity in adult male mice by van Olst, L., Kamermans, A., van der Pol, S.M.A., Rodríguez, E., Hulshof, L.A., van Dijk, R.E., Vonk, D.N., Schouten, M., Witte, M.E., de Vries, H.E., Middeldorp, J.

“…•We provide a comprehensive overview of the central and peripheral immune landscape of adult and aged male mice.•We found that CD8+ T cells expressing…”
Get full text

Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment by Voican, C.S., Mir, O., Loulergue, P., Dhooge, M., Brezault, C., Dréanic, J., Chaussade, S., Pol, S., Coriat, R.

“…Most drugs used for the treatment of solid tumors can induce hepatitis B reactivation in HBs antigen-positive patients. The risk is well documented for…”
Get full text

Familial hypomagnesemia with hipercalciuria and nephrocalcinosis associated with sensorineural hearing loss by Burgos Martín, J., Almenara Tejederas, M., Pol Heres, S., de la Prada Álvares, F., Salgueira Lazo, M.

Get full text

Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN by Fontaine, H, Kahi, S, Chazallon, C, Bourgine, M, Varaut, A, Buffet, C, Godon, O, Meritet, J F, Saïdi, Y, Michel, M L, Scott-Algara, D, Aboulker, J P, Pol, S

“…The antiviral efficacy of nucleos(t)ide analogues whose main limitation is relapse after discontinuation requires long-term therapy. To overcome the risk of…”
Get more information

The NANOGrav 12.5-Year Data Set: Dispersion Measure Misestimations with Varying Bandwidths by Sosa Fiscella, Sophia Valentina, Lam, Michael T., Arzoumanian, Zaven, Blumer, Harsha, Brook, Paul R., Cromartie, H. Thankful, DeCesar, Megan E., Demorest, Paul B., Dolch, Timothy, Ellis, Justin A., Ferdman, Robert D., Ferrara, Elizabeth C., Fonseca, Emmanuel, Garver-Daniels, Nate, Gentile, Peter A., Good, Deborah C., Jones, Megan L., Lorimer, Duncan R., Luo, Jing, Lynch, Ryan S., McLaughlin, Maura A., Ng, Cherry, Nice, David J., Pennucci, Timothy T., Pol, Nihan S., Ransom, Scott M., Spiewak, Renée, Stairs, Ingrid H., Stovall, Kevin, Swiggum, Joseph K., Vigeland, Sarah J.

“…Abstract Noise characterization for pulsar-timing applications accounts for interstellar dispersion by assuming a known frequency dependence of the delay it…”
Get full text

Development of two fine particulate matter standard reference materials (<4 μm and <10 μm) for the determination of organic and inorganic constituents by Schantz, Michele M., Cleveland, Danielle, Heckert, N. Alan, Kucklick, John R., Leigh, Stefan D., Long, Stephen E., Lynch, Jennifer M., Murphy, Karen E., Olfaz, Rabia, Pintar, Adam L., Porter, Barbara J., Rabb, Savelas A., Vander Pol, Stacy S., Wise, Stephen A., Zeisler, Rolf

“…Two new Standard Reference Materials (SRMs), SRM 2786 Fine Particulate Matter (<4 μm) and SRM 2787 Fine Particulate Matter (<10 μm) have been developed in…”
Get full text

Impact of common risk factors of fibrosis progression in chronic hepatitis C by Rüeger, S, Bochud, P-Y, Dufour, J-F, Müllhaupt, B, Semela, D, Heim, M H, Moradpour, D, Cerny, A, Malinverni, R, Booth, D R, Suppiah, V, George, J, Argiro, L, Halfon, P, Bourlière, M, Talal, A H, Jacobson, I M, Patin, E, Nalpas, B, Poynard, T, Pol, S, Abel, L, Kutalik, Z, Negro, F

“…The natural course of chronic hepatitis C varies widely. To improve the profiling of patients at risk of developing advanced liver disease, we assessed the…”
Get more information

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences by Pol, S., Haour, G., Fontaine, H., Dorival, C., Petrov‐Sanchez, V., Bourliere, M., Capeau, J., Carrieri, P., Larrey, D., Larsen, C., Marcellin, P., Pawlostky, J.‐M., Nahon, P., Zoulim, F., Cacoub, P., Ledinghen, V., Mathurin, P., Negro, F., Pageaux, G.‐P., Yazdanpanah, Y., Wittkop, L., Zarski, J.‐P., Carrat, F.

“…Summary Background Hepatitis B virus (HBV)/hepatitis C virus (HCV) confection has been rarely studied in nonasian series. Aim To compare the characteristics of…”
Get full text

The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non‐invasive fibrosis biomarkers: an international study of 2411 cases by Sebastiani, G., Castera, L., Halfon, P., Pol, S., Mangia, A., Di Marco, V., Pirisi, M., Voiculescu, M., Bourliere, M., Alberti, A.

“…Aliment Pharmacol Ther 2011; 34: 1202–1216 Summary Background  Performance of non‐invasive fibrosis biomarkers may be influenced by aetiology of chronic liver…”
Get full text

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles by P. André, F. Komurian-Pradel, S. Deforges, M. Perret, J. L. Berland, M. Sodoyer, S. Pol, C. Bréchot, G. Paranhos-Baccalà, V. Lotteau

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences—Authors’ reply by Pol, S., Haour, G., Fontaine, H., Dorival, C., Carrat, F.

“…Linked Content This article is linked to Pol et al and Huang et al papers. To view these articles visit https://doi.org/10.1111/apt.14352 and…”
Get full text

The accuracy of the FIB‐4 index for the diagnosis of mild fibrosis in chronic hepatitis B by MALLET, V., DHALLUIN‐VENIER, V., ROUSSIN, C., BOURLIERE, M., PETTINELLI, M. E., GIRY, C., VALLET‐PICHARD, A., FONTAINE, H., POL, S.

“…Summary Background  The Fib‐4 index is a simple and inexpensive biomarker to delineate liver fibrosis in chronic hepatitis C. Aim  To assess the accuracy of…”
Get full text

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24 by Saadoun, David, Resche Rigon, M, Thibault, V, Longuet, M, Pol, S, Blanc, F, Pialoux, G, Karras, A, Bazin-Karra, D, Cazorla, C, Vittecoq, D, Musset, L, Decaux, O, Ziza, J M, Lambotte, O, Cacoub, Patrice

“…The standard-of-care treatment of patients with hepatitis C virus (HCV)-mixed cryoglobulinemia (MC) vasculitis includes pegylated interferon α (PegIFN)-α plus…”
Get more information